SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SLNO (MC $24 M) Rare Disease in P3 a Potential Blockbuster
SLNO 2.935+1.6%12:24 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: BioHero9/15/2017 9:57:51 AM
   of 6
 
Great News out , if this Drug also works in Phase 3 (results expected next year) then this one will be the next Billion Dollar Company ,this unknown stock should be valued at $5 right now for their phase 3 asset .GL

Soleno Therapeutics Presents Updated Safety and Efficacy Data from Clinical Trial of DCCR for Treatment of Prader-Willi Syndrome
finance.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext